DxI 9000 Access Immunoassay Analyzer, Catalog #C11137.
Publicado el 4 de septiembre de 2024 · Inicio del retiro: 22 de mayo de 2024
Resumen
FDA registra el retiro Z-2735-2024 de dispositivos médicos de Clase II, publicado el 4 de septiembre de 2024 e iniciado el 22 de mayo de 2024. Empresa responsable: Beckman Coulter, Inc.; Estado: En curso; Cantidad reportada: 183 analyzers; Lote: Software versions 1.17.0 or below, UDI-DI 15099590732103. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
When a DxI 9000 Access Immunoassay Analyzer is connected to a Laboratory Automation System (LAS) and is running with the system software versions 1.17.0 and below, the analyzer does not send a message to the LAS when the sample wheel is full, and the LAS continues sending samples despite the limited capacity to process new samples. Therefore, sample tests may be aliquoted but not processed when the number of tests associated with onboard patient samples exceeds the throughput limit. If this issue occurs test results are flagged with a sample wheel timeout (SWT) error flag, and there may be a delay in reporting test results which could lead to a delay in patient treatment.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Beckman Coulter, Inc.
- Distribuidor
- Worldwide - US Nationwide distribution in the states of CA, FL, GA, IN, KS, ME, NH, NJ, OK, PA, TX, and WA. The countries of Australia, Austria, Bahrain, Belgium, Brazil, Croatia, Czechia, Egypt, France, Germany, Hungary, Ireland, Israel, Italy, Netherlands, New Zealand, Poland, Portugal, Slovakia, South Africa, Spain, Switzerland, Taiwan, and United Kingdom of Great Britain and Northern Ireland.
- Lote
- Software versions 1.17.0 or below, UDI-DI 15099590732103.
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAROTOR ASSY-SW40, Reference Number 331302, when the rotors are installed in the following centrifuges: Optima28 de octubre de 2026
- FDAROTOR ASSY-SW41, Reference Number 331362, when the rotors are installed in the following centrifuges: Optima28 de octubre de 2026
- FDAIQ200 SPRINT, REF: 700-3322,700-3322RFB, 700-3325, 700-3326, B48997; IQ200 SELECT, REF: 700-3340, 700-3345,21 de octubre de 2026
- FDADxU 840m Iris, REF: C76947; DxU 850m Iris, REF: C4951321 de octubre de 2026
- FDACARDIOVIT AT-180. Model Number: 0A.110000; Catalog number: 3.9205704 de septiembre de 2024
- FDAAfinion 2 Analyzer, model #1116986, US refurbished, CLIA waived.4 de septiembre de 2024
Preguntas sobre este retiro
¿DxI 9000 Access Immunoassay Analyzer, Catalog #C11137. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2735-2024 el 4 de septiembre de 2024. Peligro reportado: When a DxI 9000 Access Immunoassay Analyzer is connected to a Laboratory Automation System (LAS) and is running with the system software versions 1.17.0 and below, the analyzer does not send a message to the LAS when the sample wheel is full, and the LAS continues sending samples despite the limited capacity to process new samples. Therefore, sample tests may be aliquoted but not processed when the number of tests associated with onboard patient samples exceeds the throughput limit. If this issue occurs test results are flagged with a sample wheel timeout (SWT) error flag, and there may be a delay in reporting test results which could lead to a delay in patient treatment.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter